KEEGO HARBOR, Mich., Sept. 18, 2014 /PRNewswire/ -- Health Enhancement Products, Inc. (OTCQB: HEPI), a Michigan-based biotech firm investigating early-stage algae bioactive compounds and metabolic processes, is pleased to announce the addition of a new member to the company's board of directors. Ms. Nola E. Masterson, a California-based biotech executive and investment advisor joined the board effective September 17, 2014.

"We're very pleased and honored to have Ms. Masterson agree to join our board," states Andrew Dahl, President and CEO. "She joins us at an important inflection point in the company's growth trajectory. Her extensive knowledge and experience in life science finance and operations is an invaluable resource for all involved. Her experience as an analyst, investment advisor, executive and entrepreneur will greatly benefit the company."

Ms. Masterson, who resides in Woodside, California, has an extensive and well-regarded track record in the biotech industry. Since 1982, she has been the Chief Executive Officer of Science Futures Inc., an investment and advisory firm, and is currently Managing Member and General Partner of Science Futures LLC, I and II, which are venture capital funds invested in life science funds and companies. As Board Chair of Repros Therapeutics, Inc., Ms. Masterson also serves on the audit committee, nominating committee and compensation committee. She was the first biotechnology analyst on Wall Street, working with Drexel Burnham Lambert and Merrill Lynch, and is a co-founder of Sequenom, Inc., a genetic analysis company located in San Diego and Hamburg, Germany. Ms. Masterson is the Chair Emeritus of the Bay Bio Institute, a 501(c)3 affiliate of BayBio, which promotes science education, workforce development and best practices as well as entrepreneurs in the bioeconomy.

Her business career began at Ames Company, a division of Bayer, and was followed by eight years at Millipore Corporation in sales and sales management. Ms. Masterson has 33 years of experience in the life science industry. She received her Masters' degree in Biological Sciences from George Washington University, and continued Ph.D. coursework at the University of Florida.

About Health Enhancement Products, Inc.

Health Enhancement Products, Inc. (OTCQB: HEPI) is a Michigan-based biotech company engaged in the investigation of the health benefits of early-stage bioactive compounds, the development of natural bioactive compounds for use as dietary supplements and food ingredients, as well as convergence products in the field of metabolomics.

SOURCE Health Enhancement Products, Inc.

Copyright 2014 PR Newswire

Zivo Bioscience (QB) (USOTC:ZIVO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Zivo Bioscience (QB) Charts.
Zivo Bioscience (QB) (USOTC:ZIVO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Zivo Bioscience (QB) Charts.